← Leaderboards
Yanqiao Zhang
Northeast Ohio Medical University
$17,285,691
Attributed
$18,066,431
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,066,431 · 11
By mechanism
R01$17,206,481 · 9
R15$462,000 · 1
R21$397,950 · 1
Top collaborators
- Liya Yin4 shared
Others in their field
Top investigators on “Hepatic”
- Judith S. Currier · University Of California Los Angeles$284,891,719
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,049,347
- Constance Ann Benson · University Of California, San Diego$185,061,530
- Daniel R Kuritzkes · Brigham And Women'S Hospital$174,515,698
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$146,381,332
- Sharon A Nachman · Johns Hopkins University$135,132,510
Research focus
HepaticLiverPlayLipidsPreventBile AcidsMemberRegulationOverexpressionTriglyceridesLeadCholesterolFatty LiverLipid MetabolismHepatocyteObesityHigh Fat DietInflammationBaseGenesNonalcoholic SteatohepatitisCholesterol HomeostasisRisk FactorsPathogenesis
Grant awards (42)
Hepatocyte TMEM141 in Lipoprotein Metabolism$744,453
R01 · FY2025 · HL · contact PI
Hepatocyte FOXA3 in Alcohol-Associated Liver Disease$639,177
R01 · FY2025 · AA · contact PI
Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease$543,615
R01 · FY2025 · DK · contact PI
Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease$584,539
R01 · FY2024 · DK · contact PI
Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease$608,895
R01 · FY2023 · DK · contact PI
Forkhead Box A3 and Bile Acid Metabolism$530,453
R01 · FY2023 · DK · contact PI
Forkhead Box A3 and Bile Acid Metabolism$1
R01 · FY2023 · DK · contact PI
Forkhead Box A3 and Bile Acid Metabolism$535,603
R01 · FY2022 · DK · contact PI
Hepatic FOXA3 Links NAFLD to Atherosclerosis$511,155
R01 · FY2022 · DK · contact PI
Forkhead Box A3 and Bile Acid Metabolism$535,603
R01 · FY2021 · DK · contact PI
Identification of Novel Genes/Pathways That Regulate Atherogenesis$515,277
R01 · FY2021 · HL · contact PI
Hepatic FOXA3 Links NAFLD to Atherosclerosis$485,132
R01 · FY2021 · DK · contact PI
Role of Hepatocyte ATF3 in NAFLD$458,214
R01 · FY2021 · DK · contact PI
Forkhead Box A3 and Bile Acid Metabolism$535,603
R01 · FY2020 · DK · contact PI
Identification of Novel Genes/Pathways That Regulate Atherogenesis$515,277
R01 · FY2020 · HL · contact PI
Hepatic FOXA3 Links NAFLD to Atherosclerosis$511,155
R01 · FY2020 · DK · contact PI
Role of Hepatocyte ATF3 in NAFLD$458,214
R01 · FY2020 · DK · contact PI
Identification of Novel Genes/Pathways That Regulate Atherogenesis$515,277
R01 · FY2019 · HL · contact PI
Hepatic FOXA3 Links NAFLD to Atherosclerosis$511,155
R01 · FY2019 · DK · contact PI
Role of Hepatocyte ATF3 in NAFLD$458,214
R01 · FY2019 · DK · contact PI
Regulation of Lipid and Lipoprotein Metabolism by Nuclear Receptors$390,370
R01 · FY2019 · HL · contact PI
Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease$341,100
R01 · FY2019 · DK · contact PI
Identification of Novel Genes/Pathways That Regulate Atherogenesis$515,277
R01 · FY2018 · HL · contact PI
Role of Hepatocyte ATF3 in NAFLD$458,214
R01 · FY2018 · DK · contact PI
Regulation of Lipid and Lipoprotein Metabolism by Nuclear Receptors$390,370
R01 · FY2018 · HL · contact PI
Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease$341,100
R01 · FY2018 · DK · contact PI
Regulation of Lipid and Lipoprotein Metabolism by Nuclear Receptors$390,370
R01 · FY2017 · HL · contact PI
Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease$341,100
R01 · FY2017 · DK · contact PI
Carboxylesterase 1 in Alcoholic Liver Disease$180,025
R21 · FY2017 · AA · contact PI
Regulation of Lipid and Lipoprotein Metabolism by Nuclear Receptors$390,370
R01 · FY2016 · HL · contact PI
Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease$341,100
R01 · FY2016 · DK · contact PI
Carboxylesterase 1 in Alcoholic Liver Disease$217,925
R21 · FY2016 · AA · contact PI
Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease$341,100
R01 · FY2015 · DK · contact PI
Identification of Novel Genes/Pathways That Regulate Lipid and Glucose Metabolism$327,250
R01 · FY2015 · DK · contact PI
Regulation of Lipid and Lipoprotein Metabolism by Nuclear Receptors$377,300
R01 · FY2014 · HL · contact PI
Identification of Novel Genes/Pathways That Regulate Lipid and Glucose Metabolism$322,201
R01 · FY2014 · DK · contact PI
Regulation of Lipid and Lipoprotein Metabolism by Nuclear Receptors$366,520
R01 · FY2013 · HL · contact PI
Identification of Novel Genes/Pathways That Regulate Lipid and Glucose Metabolism$312,254
R01 · FY2013 · DK · contact PI
Regulation of Lipid and Lipoprotein Metabolism by Nuclear Receptors$385,000
R01 · FY2012 · HL · contact PI
Identification of Novel Genes/Pathways That Regulate Lipid and Glucose Metabolism$307,513
R01 · FY2012 · DK · contact PI
Regulation of Lipid and Lipoprotein Metabolism by Nuclear Receptors$370,960
R01 · FY2011 · HL · contact PI
Hepatocyte Nuclear Factor 4alpha and Lipid Homeostasis$462,000
R15 · FY2010 · DK · contact PI